Océanie · Marchés régionaux · Stockhead

Recce inks Australia and NZ licensing deal for diabetic foot infections gel

Publié par Stockhead · Australie il y a 1 h

Under the deal, Arrotex will obtain exclusive commercialisation rights for R327G in Australia and New Zealand. ... Read More The post Recce inks Australia and NZ licensing deal…

Lire l'article complet sur Stockhead Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stockhead.com.au)

Recce inks Australia and NZ licensing deal for diabetic foot infections gel

À lire aussi

Pumped hydro project scrapped after developer deems it unviable

Water works to free up western suburbs land

Victoria’s government-backed Alice Anderson Fund for women founders scores another $10 million

IFM continues global infra drive with appointment, acquisition

The 100-year bond and the two-year chip

Cuttable raises $20 million to help brands post social media ads at scale

Recce inks Australia and NZ licensing deal for diabetic foot infections gel

Partager

À lire aussi

Pumped hydro project scrapped after developer deems it unviable

Water works to free up western suburbs land

Victoria’s government-backed Alice Anderson Fund for women founders scores another $10 million

IFM continues global infra drive with appointment, acquisition

The 100-year bond and the two-year chip

Cuttable raises $20 million to help brands post social media ads at scale